S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
Highly Profitable Restaurant Brand Expands to Canada (Ad)
Stock market today: Asian markets mostly higher after Biden-McCarthy deal on US debt
PwC Australia sidelines 9 directors as leak of tax information investigated
Highly Profitable Restaurant Brand Expands to Canada (Ad)
North Korea notifies neighboring Japan it plans to launch satellite in coming days
Drought-struck Barcelona quenches thirst with costly desalination
World-Renowned Brazilian Restaurant Debuts in Canada (Ad)
Takeaways on debt ceiling: McCarthy's balancing act, Biden's choice and the challenges ahead
Debt ceiling agreement gets thumbs up from business groups, jeers from some on political right
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
Highly Profitable Restaurant Brand Expands to Canada (Ad)
Stock market today: Asian markets mostly higher after Biden-McCarthy deal on US debt
PwC Australia sidelines 9 directors as leak of tax information investigated
Highly Profitable Restaurant Brand Expands to Canada (Ad)
North Korea notifies neighboring Japan it plans to launch satellite in coming days
Drought-struck Barcelona quenches thirst with costly desalination
World-Renowned Brazilian Restaurant Debuts in Canada (Ad)
Takeaways on debt ceiling: McCarthy's balancing act, Biden's choice and the challenges ahead
Debt ceiling agreement gets thumbs up from business groups, jeers from some on political right
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
Highly Profitable Restaurant Brand Expands to Canada (Ad)
Stock market today: Asian markets mostly higher after Biden-McCarthy deal on US debt
PwC Australia sidelines 9 directors as leak of tax information investigated
Highly Profitable Restaurant Brand Expands to Canada (Ad)
North Korea notifies neighboring Japan it plans to launch satellite in coming days
Drought-struck Barcelona quenches thirst with costly desalination
World-Renowned Brazilian Restaurant Debuts in Canada (Ad)
Takeaways on debt ceiling: McCarthy's balancing act, Biden's choice and the challenges ahead
Debt ceiling agreement gets thumbs up from business groups, jeers from some on political right
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
Highly Profitable Restaurant Brand Expands to Canada (Ad)
Stock market today: Asian markets mostly higher after Biden-McCarthy deal on US debt
PwC Australia sidelines 9 directors as leak of tax information investigated
Highly Profitable Restaurant Brand Expands to Canada (Ad)
North Korea notifies neighboring Japan it plans to launch satellite in coming days
Drought-struck Barcelona quenches thirst with costly desalination
World-Renowned Brazilian Restaurant Debuts in Canada (Ad)
Takeaways on debt ceiling: McCarthy's balancing act, Biden's choice and the challenges ahead
Debt ceiling agreement gets thumbs up from business groups, jeers from some on political right
OTCMKTS:ASCLF

Ascletis Pharma (ASCLF) Stock Forecast, Price & News

$0.34
-0.03 (-8.57%)
(As of 05/18/2023)
Compare
Today's Range
$0.34
$0.34
50-Day Range
$0.31
$0.62
52-Week Range
$0.31
$0.62
Volume
1,000 shs
Average Volume
2,670 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ASCLF stock logo

About Ascletis Pharma (OTCMKTS:ASCLF) Stock

Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China and internationally. The company offers Ritonavir oral tablet, a pharmacokinetic booster of various oral antiviral drugs targeting viral proteases and a component of the approved oral antiviral drug Paxlovid; ASCLEVIR and GANOVO for the treatment of Hepatitis C virus. It is also developing ASC22 for treating chronic hepatitis B (CHB) and human immunodeficiency virus functional cure; ASC42 for chronic hepatitis B functional cure; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, ASC42, ASC43F FDC, ASC44F FDC, and ASC45F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis. In addition, the company is developing ASC40 to treat recurrent glioblastoma, drug resistant breast cancer, and KRAS mutant non-small cell lung cancer; ASC61 and ASC63 for advanced solid tumors; ASC60 to treat solid tumors; and ASC40 for the treatment of acne, Ascletis Pharma Inc. was founded in 2013 and is headquartered in Hangzhou, the People's Republic of China.

Receive ASCLF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ascletis Pharma and its competitors with MarketBeat's FREE daily newsletter.

ASCLF Stock News Headlines

"Chilling War Games Show US Forces Crushed" – FOX NEWS
=== BREAKING === "Chilling War Games Show US Forces Crushed" - FOX NEWS After losing to China in repeated war games, U.S. military to spend billions on new "living missile" for armed forces. Investors stand to reap 35,960% on shares of small defense contractor that makes powerful new weapon. Get the name of the stock here >>>
"Chilling War Games Show US Forces Crushed" – FOX NEWS
=== BREAKING === "Chilling War Games Show US Forces Crushed" - FOX NEWS After losing to China in repeated war games, U.S. military to spend billions on new "living missile" for armed forces. Investors stand to reap 35,960% on shares of small defense contractor that makes powerful new weapon. Get the name of the stock here >>>
Ascletis Pharma Announces IND Approval For ASC11 In China - Quick Facts
See More Headlines
Receive ASCLF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ascletis Pharma and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:ASCLF
CIK
N/A
Phone
N/A
Fax
N/A
Employees
266
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Dr. Jinzi Jason Wu (Age 60)
    Founder, Chairman & CEO
  • Dr. Handan He Ph.D. (Age 61)
    Chief Scientific Officer
  • Ms. Hejingdao Wu (Age 49)
    Sr. VP of Operations & Exec. Director
  • Ms. Yuemei Yan (Age 53)
    Sr. VP of Clinical Devel. Operations
  • Dr. Kristjan Sigurdur Gudmundsson (Age 55)
    Sr. Consultant & Head of Discovery
  • Dr. George Zhengzhi Hill (Age 72)
    Sr. Consultant & Chief Medical Advisor
  • Mr. John P. Gargiulo M.B.A.
    Chief Bus. Officer
  • Mr. Ming Fai Chung CPA
    Company Sec.













ASCLF Stock - Frequently Asked Questions

How have ASCLF shares performed in 2023?

Ascletis Pharma's stock was trading at $0.55 at the start of the year. Since then, ASCLF shares have decreased by 37.4% and is now trading at $0.3445.
View the best growth stocks for 2023 here
.

Are investors shorting Ascletis Pharma?

Ascletis Pharma saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 743,300 shares, an increase of 5.4% from the April 30th total of 705,000 shares. Based on an average trading volume of 4,200 shares, the days-to-cover ratio is currently 177.0 days.
View Ascletis Pharma's Short Interest
.

What is Ascletis Pharma's stock symbol?

Ascletis Pharma trades on the OTCMKTS under the ticker symbol "ASCLF."

How do I buy shares of Ascletis Pharma?

Shares of ASCLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ascletis Pharma's stock price today?

One share of ASCLF stock can currently be purchased for approximately $0.34.

How many employees does Ascletis Pharma have?

The company employs 266 workers across the globe.

This page (OTCMKTS:ASCLF) was last updated on 5/29/2023 by MarketBeat.com Staff

My Account -